Attached files

file filename
10-Q - QUARTERLY REPORT FOR THE PERIOD ENDED MAY 31, 2011 - THERALINK TECHNOLOGIES, INC.form10q.htm
EX-32.2 - SECTION 906 CERTIFICATION - THERALINK TECHNOLOGIES, INC.exhibit32-2.htm
EX-31.1 - SECTION 302 CERTIFICATION - THERALINK TECHNOLOGIES, INC.exhibit31-1.htm
EX-31.2 - SECTION 302 CERTIFICATION - THERALINK TECHNOLOGIES, INC.exhibit31-2.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, Cameron Durrant, hereby certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that

1.

the quarterly report on Form 10-Q of PediatRx Inc. for the period ended May 31, 2011 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

   
2.

the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of PediatRx Inc.

 

July 8, 2011 /s/ Cameron Durrant
  Cameron Durrant
  President, Chief Executive Officer and Director
  (Principal Executive Officer)